Symbotex™ Composite Mesh For Surgical Laparoscopic And Open Ventral Hernia Repair Is Designed To Offer Patients Optimal Hernia Repair Performance. (Photo: Business Wire)

Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs.
Symbotex™ composite mesh for surgical laparoscopic and open ventral hernia repair is designed to off ...

Symbotex™ composite mesh for surgical laparoscopic and open ventral hernia repair is designed to offer patients optimal hernia repair performance. (Photo: Business Wire)

A ventral hernia can develop when the outer layers of the abdominal wall weaken, bulge or tear, with most hernias resulting from strain on the abdominal muscles. Hernias can grow larger over time and cause serious complications if not surgically repaired.

“Through ongoing collaboration with our customers we know there is a need for a mesh that is easy to use and provides optimal repair for patients and we believe Symbotex provides the best of both worlds,” said Rob Claypoole, vice president and general manager, Hernia Care, Covidien. “With the addition of Symbotex, our hernia product line offers surgeons an even broader choice of unique solutions to address diverse patient needs.”

Symbotex composite mesh is dual sided, comprising a macroporous monofilament, hydrophilic textile in a three-dimensional construction that allows for reinforced strength, memory shape and significant tissue ingrowth. A bioabsorbable collagen film on the visceral side minimizes tissue attachments.

Symbotex mesh offers surgeons improved ease of use with an orientation marker that facilitates correctly placing the mesh over the hernia defect. Additionally, Symbotex mesh is transparent, offering improvements to the visualization of the anatomy during mesh placement and fixation. Symbotex composite mesh is available in a variety of shapes and sizes for laparoscopic and open ventral hernia repair.

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback